Advances in the Management of Bladder and Kidney Cancer: A Multidisciplinary Approach

Advances in the Management of Bladder and Kidney Cancer: A Multidisciplinary Approach is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held from Oct 24 - 26, 2019 at Mortimer B. Zuckerman Research Center, New York City, New York, United States of America.

The target audience for this medical event includes urologists, urologic-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, and allied health professions.

Accreditation:
AMA Credit Designation Statement
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Overview:
The course objective is to advance and disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer. The program will include comprehensive state-of-the art lectures and discussions encouraging the exchange of ideas between faculty (radiologists, pathologists, surgeons, radiation oncologists, and medical oncologists) and the audience. Discussions will center on the multidisciplinary management of bladder and kidney cancer.

Objectives:
• To present a multidisciplinary approach to the management of bladder and kidney cancer including surgery, medical oncology, and radiation therapy.
• To advance and disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer

Additional details will be posted as soon as they are available.